Literature DB >> 17275546

Treatment compliance in patients lost to follow-up after polysomnography.

Ho-Sheng Lin1, Giancarlo Zuliani, Esmael H Amjad, Abhishek S Prasad, M Safwan Badr, Chuan-Ju G Pan, James A Rowley.   

Abstract

OBJECTIVES: Studies on positive airway pressure (PAP) compliance typically focus only on patients who returned for follow-up. In this study, we examined patients who failed to follow-up after their initial polysomnogram (PSG) and PAP titration to determine their treatment status in terms of PAP usage. STUDY
DESIGN: On retrospective chart review, we identified 57 patients who, based on PSG findings and symptoms, required the use of PAP but failed to follow-up after titration. Twenty-five of these patients were successfully contacted and agreed to an interview.
RESULTS: Only 7 (28%) patients were using PAP on a regular basis. The remaining 18 (72%) patients were noncompliant.
CONCLUSIONS: A significant proportion (24%) of OSA patients who required treatment with PAP were lost to follow-up after polysomnography. This group of patients has previously been ignored in the literature. We showed in this study that majority (72%) of these patients were not being treated adequately for OSA.

Entities:  

Mesh:

Year:  2007        PMID: 17275546     DOI: 10.1016/j.otohns.2006.08.007

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  12 in total

1.  Short-term CPAP adherence in obstructive sleep apnea: a big data analysis using real world data.

Authors:  Peter A Cistulli; Jeff Armitstead; Jean-Louis Pepin; Holger Woehrle; Carlos M Nunez; Adam Benjafield; Atul Malhotra
Journal:  Sleep Med       Date:  2019-01-11       Impact factor: 3.492

Review 2.  On the cutting edge of obstructive sleep apnoea: where next?

Authors:  Atul Malhotra; Jeremy E Orr; Robert L Owens
Journal:  Lancet Respir Med       Date:  2015-04-14       Impact factor: 30.700

3.  Large telemonitoring databases: the good, the bad, and the useful.

Authors:  Timothy I Morgenthaler
Journal:  J Clin Sleep Med       Date:  2021-12-01       Impact factor: 4.062

4.  Design and rationale for the treating Obstructive Sleep Apnea using Targeted Hypoglossal Nerve Stimulation (OSPREY) trial.

Authors:  Ofer Jacobowitz; Alan R Schwartz; Eric G Lovett; Giovanni Ranuzzi; Atul Malhotra
Journal:  Contemp Clin Trials       Date:  2022-05-22       Impact factor: 2.261

5.  Associated predictors of therapeutic response to uvulopharyngopalatoplasty for severe obstructive sleep apnea hypopnea syndrome.

Authors:  Su Ru Liu; Hong Liang Yi; Shan Kai Yin; Jian Guan; Bin Chen; Li Li Meng; Kai Ming Su
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-02-27       Impact factor: 2.503

Review 6.  Potential therapeutic targets in obstructive sleep apnoea.

Authors:  Julian P Saboisky; Nancy L Chamberlin; Atul Malhotra
Journal:  Expert Opin Ther Targets       Date:  2009-07       Impact factor: 6.902

7.  Patient Engagement Using New Technology to Improve Adherence to Positive Airway Pressure Therapy: A Retrospective Analysis.

Authors:  Atul Malhotra; Maureen E Crocker; Leslee Willes; Colleen Kelly; Sue Lynch; Adam V Benjafield
Journal:  Chest       Date:  2017-11-15       Impact factor: 9.410

8.  Continuous Positive Airway Pressure Compliance in Patients with Obstructive Sleep Apnea.

Authors:  Shahla Afsharpaiman; Ehsan Shahverdi; Encieh Vahedi; Hossein Aqaee
Journal:  Tanaffos       Date:  2016

9.  Machine learning-based preoperative datamining can predict the therapeutic outcome of sleep surgery in OSA subjects.

Authors:  Jin Youp Kim; Hyoun-Joong Kong; Su Hwan Kim; Sangjun Lee; Seung Heon Kang; Seung Cheol Han; Do Won Kim; Jeong-Yeon Ji; Hyun Jik Kim
Journal:  Sci Rep       Date:  2021-07-21       Impact factor: 4.379

10.  Longitudinal brain structural alterations and systemic inflammation in obstructive sleep apnea before and after surgical treatment.

Authors:  Wei-Che Lin; Chih-Cheng Huang; Hsiu-Ling Chen; Kun-Hsien Chou; Pei-Chin Chen; Nai-Wen Tsai; Meng-Hsiang Chen; Michael Friedman; Hsin-Ching Lin; Cheng-Hsien Lu
Journal:  J Transl Med       Date:  2016-05-17       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.